Willis H Navarro
Affiliation: Genentech Inc
- AIDS-related lymphoproliferative diseaseWillis H Navarro
Division of Hematology Oncology, University of California, San Francisco, 400 Parnassus Ave, Rm A502, San Francisco, CA 94143, USA
Blood 107:13-20. 2006..Significant progress has been made in the understanding and management of ARL but outcomes still remain inferior compared to those achieved in HIV- individuals...
- Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantationWillis H Navarro
University of California, San Francisco, San Francisco, California 94080 4990, and University Hospitals of Cleveland, OH, USA
Biol Blood Marrow Transplant 12:541-51. 2006....
- Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplantSonali M Smith
Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA
Biol Blood Marrow Transplant 14:904-12. 2008..HCT2 should be considered for patients with relapsed HL or NHL after HCT1 without alternative allogeneic stem cell transplant options...
- Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minoritiesChristopher J Schwake
Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
Biol Blood Marrow Transplant 11:988-98. 2005..Our results suggest that the inferior survival reported in ethnic minorities after HSCT may not be readily explained by center effects...